Frontiers in Pharmacology

Original Research

Accepted on 18 Apr 2025

Albiflorin inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis in mice

in Gastrointestinal and Hepatic Pharmacology

Lingjie Meng
Huijing Lv
Anli Liu
Qian Cao
Xinyi Du
Chengjin Li
Qinggui Li
Qingqing Luo
Yi Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1577201

240 views

Original Research

Accepted on 18 Apr 2025

The impact of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin dose requirement in Saudi patients

in Pharmacogenetics and Pharmacogenomics

Salha Jokhab
MAHA Meshal ALRASHEED
Dana Bakheet
Abdulkareem Almomen
Nouf Alaboud
Farhad Kamali

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1547142

Review

Accepted on 18 Apr 2025

Curcumin: A potential anti-photoaging agent

in Inflammation Pharmacology

Yuhong Nie
Yiming Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1559032

Original Research

Accepted on 18 Apr 2025

Beta-boswellic Acid Facilitates Diabetic Wound Healing by Targeting STAT3 and Inhibiting Ferroptosis in Fibroblasts

in Ethnopharmacology

Ziyang Han
Weiping Wu
Zeming Bai
Yiping Xiu
Dapeng Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578625

Original Research

Accepted on 18 Apr 2025

Adverse drug events associated with Insulin glargine: a real-world pharmacovigilance study based on the FAERS database

in Experimental Pharmacology and Drug Discovery

Wang Tongtong
Gefei He
Wan Xiong
Huang Juanjuan

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1563238

Review

Accepted on 18 Apr 2025

The research progress on radionuclides in osteoporosis diagnosis and drug efficacy monitoring

in Experimental Pharmacology and Drug Discovery

Jie FU
Chi Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1594903

Original Research

Accepted on 18 Apr 2025

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Shuning Chen
Weimin Kong
Xiaochang Shen
Nikita Sinha
Jennifer Haag
Boer Deng
Haomeng Zhang
Catherine John
Wenchuan Sun
Chunxiao Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1520771

Original Research

Accepted on 18 Apr 2025

Gen-miR-5 Derived from Gentianella acuta Inhibits PFKP to Prevent Fibroblast Activation and Alleviate Myocardial Fibrosis

in Experimental Pharmacology and Drug Discovery

Hongyao Ge
Zhenyu Du
Weizhe Liu
LeTian Wang
Junyang Li
Gaoshan Yang
Aiying Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1578877

Review

Accepted on 18 Apr 2025

Gut Microbiota: A New Target for the Prevention and Treatment of Insomnia Using Chinese Herbal Medicines and Their Active Components

in Ethnopharmacology

Changmei Wu
Jinjin Dou
xiaoxue song
Fang Yang
xuan Liu
Weipeng song
Xiwu Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1572007

Review

Accepted on 18 Apr 2025

Pharmacological Potential of Natural Chalcones: A Recent Studies and Future Perspective

in Ethnopharmacology

Suman Adhikari
Priyatosh Nath
Vishal Kumar Dev
Dr. Niranjan Das
Antara Banerjee
Surajit Pathak
Asim K Duttaroy

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1570385

Original Research

Accepted on 18 Apr 2025

Harmine derivative B-9-3 inhibits non-small cell lung cancer via the VEGFA/PI3K/AKT pathway

in Ethnopharmacology

Yuche Wu
Bing Wang
Xuwen Mao
Wei Chen
HAJI Akber Aisa

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1526952

123 views

Original Research

Accepted on 18 Apr 2025

Bioactive Lipids and Allelopathic Potential of the Invasive Plant Heracleum sosnowskyi: Insights into Its Fatty Acid Composition, Antimicrobial and Cytotoxic Effects

in Ethnopharmacology

Eva Borska
Jorens Kviesis
Anna Ramata-Stunda
Vizma Nikolajeva
Linda Ansone-Bertina
Martins Boroduskis
Maris Klavins

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1582694

Original Research

Accepted on 18 Apr 2025

Serum 25(OH)D and plasma fatty acids on breast and gastric tumors: A cross-sectional study in Northeast China

in Pharmacology of Anti-Cancer Drugs

Yu Zhong
Liyuan Ke
Su Li

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1567568

Editorial

Accepted on 18 Apr 2025

Advancements in Sex-Specific Tumor Heterogeneity

in Pharmacology of Anti-Cancer Drugs

Prem Prakash Kushwaha
SWATI KUSHWAHA
Radha Kushwaha

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1598740

General Commentary

Accepted on 18 Apr 2025

Commentary: Triclabendazole Induces Pyroptosis by Activating Caspase-3 to Cleave GSDME in Breast Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Jie Guo
Wen-Long Peng
Chen Guang Li
Yulong Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1583920

Case Report

Accepted on 18 Apr 2025

Crizotinib for ROS1 SCLC Case report: Durable response of immuno-chemotherapy targeting a rare ROS1 fusion-positive extensive-stage SCLC patient after primary resistance to crizotinib

in Pharmacology of Anti-Cancer Drugs

Mengli Qiu
Sisi Wang
Peiwen Guo
Yong Zhu
Siqi Wu
Huiting Peng
Zehuai Guo
Yanmeng Guo
Jieheng Lin
Yang Cao

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1522542